Carderock Capital Management Inc Novo Nordisk A S Transaction History

Carderock Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$95.88 - $117.08 $119,850 - $146,350	-1,250 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$84.42 - $106.62 $105,525 - $133,275	1,250 New	1,250 $120,000
Q2 2019 Jul 15, 2019	SELL	$46.79 - $52.47 $257,391 - $288,637	-5,501 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $41 - $47	-1 Reduced 0.02%	5,501 $253,000
Q3 2018 Nov 13, 2018	SELL	$46.76 - $51.24 $46 - $51	-1 Reduced 0.02%	5,502 $259,000
Q1 2018 Apr 27, 2018	SELL	$48.49 - $58.14 $3,636 - $4,360	-75 Reduced 1.34%	5,503 $271,000
Q3 2017 Nov 15, 2017	SELL	$41.15 - $49.22 $13,373 - $15,996	-325 Reduced 5.51%	5,578 $269,000
Q2 2017 Aug 10, 2017	BUY	N/A	5,903	5,903 $253,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Carderock Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Carderock Capital Management Inc with notifications on news.